Investing in founders redefining the frontiers of medicine and healthcare — from therapeutics and life sciences to care delivery and health infrastructure. Focus on AI in bio+health, digital health, and next-generation drug discovery. Most recent fund: $700M a16z Bio+Health fund announced January 2026.